Last reviewed · How we verify
NCT07338929: FRAIL-KTx
Physical Performance Assessment in Kidney Transplant Evaluation
trial in Frailty Syndrome in 50 participants. Currently enrolling.
31 October 2027
Quick facts
| Lead sponsor | University Hospital, Martin |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 1 October 2025 |
| Primary completion | 31 October 2027 |
| Estimated completion | 31 October 2028 |
| Sites | 1 location across Slovakia |
Conditions studied
- Frailty Syndrome — all drugs for Frailty Syndrome →
Sponsor
University Hospital, Martin
Who can join
18 and older, any sex, with Frailty Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective cohort study investigates physical frailty, assessed by the Short Physical Performance Battery (SPPB), in patients evaluated for kidney transplantation. The study aims to compare SPPB scores before listing, annually during the waiting period, and after transplantation at 6 and 12 months. It also includes a control group of dialysis patients not eligible for transplantation to evaluate differences in physical performance. The goal is to understand how frailty impacts transplant outcomes and patient recovery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07338929
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Frailty Syndrome
Currently open trials in the same condition.
- NCT07465159 — Multimodal Prehabilitation of Frail Patients Undergoing Elective Knee or Hip Replacement · NA · recruiting
- NCT07258615 — Longitudinal Ultrasound Assessment of Diaphragmatic and Respiratory Muscle Function Following Respiratory Muscle Trainin · NA · active not recruiting
- NCT07348081 — Real World Evidence to Assess the Value of a Digital Care Coordination and Monitoring Program for Supporting Caregivers · NA · recruiting
- NCT07071142 — Frailty and Outcomes in Older Heart Failure Patients With Ejection Fraction >40% · active not recruiting
- NCT07180147 — Arlington Longitudinal Optimal Healthy Aging Study (ALOHA) · active not recruiting
Other University Hospital, Martin trials
Trials by the same sponsor.
- NCT07274462 — DARA-MVI Study (Daratumumab for Microvascular Inflammation in Kidney Transplantation) · Phase 4 · active not recruiting
- NCT06929637 — Amino Acid Infusion in Kidney Transplant Recipients · NA · not yet recruiting
- NCT07081126 — Daratumumab for Late Antibody-Mediated Rejection · NA · recruiting
- NCT07055984 — Predicting Outcomes in Posttransplant Diabetes Mellitus Via microRNA · recruiting
- NCT07024238 — Impact of SCFA Supplementation on Gut Microbiome Composition of Kidney Transplant Recipients · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07338929 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Martin
- Last refreshed: 14 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07338929.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing